1. Home
  2. FOXO vs ADXN Comparison

FOXO vs ADXN Comparison

Compare FOXO & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOXO
  • ADXN
  • Stock Information
  • Founded
  • FOXO 2019
  • ADXN 2002
  • Country
  • FOXO United States
  • ADXN Switzerland
  • Employees
  • FOXO N/A
  • ADXN N/A
  • Industry
  • FOXO Retail: Computer Software & Peripheral Equipment
  • ADXN Biotechnology: Pharmaceutical Preparations
  • Sector
  • FOXO Technology
  • ADXN Health Care
  • Exchange
  • FOXO Nasdaq
  • ADXN Nasdaq
  • Market Cap
  • FOXO 4.9M
  • ADXN 8.0M
  • IPO Year
  • FOXO N/A
  • ADXN N/A
  • Fundamental
  • Price
  • FOXO $0.24
  • ADXN $7.36
  • Analyst Decision
  • FOXO
  • ADXN Strong Buy
  • Analyst Count
  • FOXO 0
  • ADXN 1
  • Target Price
  • FOXO N/A
  • ADXN $30.00
  • AVG Volume (30 Days)
  • FOXO 9.1M
  • ADXN 15.1K
  • Earning Date
  • FOXO 11-19-2024
  • ADXN 03-24-2025
  • Dividend Yield
  • FOXO N/A
  • ADXN N/A
  • EPS Growth
  • FOXO N/A
  • ADXN N/A
  • EPS
  • FOXO N/A
  • ADXN 0.06
  • Revenue
  • FOXO $1,341,000.00
  • ADXN $701,260.00
  • Revenue This Year
  • FOXO N/A
  • ADXN N/A
  • Revenue Next Year
  • FOXO N/A
  • ADXN N/A
  • P/E Ratio
  • FOXO N/A
  • ADXN $1.01
  • Revenue Growth
  • FOXO 196.03
  • ADXN N/A
  • 52 Week Low
  • FOXO $0.13
  • ADXN $6.73
  • 52 Week High
  • FOXO $1.30
  • ADXN $27.90
  • Technical
  • Relative Strength Index (RSI)
  • FOXO 46.29
  • ADXN 46.90
  • Support Level
  • FOXO $0.20
  • ADXN $6.73
  • Resistance Level
  • FOXO $0.23
  • ADXN $7.90
  • Average True Range (ATR)
  • FOXO 0.02
  • ADXN 0.38
  • MACD
  • FOXO 0.00
  • ADXN -0.05
  • Stochastic Oscillator
  • FOXO 52.70
  • ADXN 39.55

About FOXO FOXO Technologies Inc.

FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: